| FFAFX | VVPLX | FFAFX / VVPLX | |
| Total Expense Ratio | 0.34 | 1.10 | 31% |
| Annual Report Gross Expense Ratio | 0.34 | 1.19 | 29% |
| Fund Existence | 6 years | 17 years | - |
| Gain YTD | 7.309 | -1.285 | -569% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 5000 | 5% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 357B | 220M | 162,273% |
| Annual Yield % from dividends | 0.45 | 1.43 | 31% |
| Returns for 1 year | 4.65 | -3.22 | -144% |
| Returns for 3 years | 40.62 | 31.94 | 127% |
| Returns for 5 years | 18.04 | -10.78 | -167% |
| Returns for 10 years | N/A | 74.25 | - |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| RSF | 14.60 | -0.01 | -0.07% |
| RiverNorth Capital and Income Fund | |||
| UJAN | 45.50 | -0.07 | -0.16% |
| Innovator US Equity Ultra Buff ETF™ Jan | |||
| GSKH | 73.13 | -0.39 | -0.53% |
| GSK PLC ADRHEDGED | |||
| FLQL | 77.56 | -0.73 | -0.93% |
| Franklin US Large Cap Mltfctr Idx ETF | |||
| QDVO | 29.76 | -0.31 | -1.03% |
| Amplify CWP Growth & Income ETF | |||